申请人:Ischemix LLC
公开号:US20160264622A1
公开(公告)日:2016-09-15
The present invention relates to compositions comprising a substantially pure compound represented by Structural Formula I:
and methods of using such compounds to activate cytoprotective kinases. The values and preferred values of the variables in Structural Formula I are defined herein.
本发明涉及包含由结构式I代表的基本纯化合物的组合物,以及利用这些化合物来激活细胞保护激酶的方法。结构式I中变量的值和首选值在本文中有定义。